Cardiovascular Diseases Clinical Trial
Official title:
Effectiveness of Hospital Fit on Physical Activity of Hospitalised Patients: a Stepped-wedge Cluster-randomised Clinical Trial and Process Evaluation
NCT number | NCT05378724 |
Other study ID # | NL |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2022 |
Est. completion date | March 31, 2023 |
Verified date | September 2022 |
Source | Maastricht University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of this study is to investigate the effectiveness of using Hospital Fit as part of the physiotherapy treatment on average time spent walking per day in patients hospitalised at the Medical Oncology or Cardiology Departments of the Maastricht University Medical Center (MUMC+) and Radboud University Medical Center (Radboudumc) compared to patients who received physiotherapy before implementation of Hospital Fit. Secondary: to investigate the effectiveness of using Hospital Fit as part of the physiotherapy treatment on average time spent standing per day, average time spent lying/sitting per day, average number of transitions per day and the Modified Iowa Level of Assistance scale (mILAS) scores in hospitalised patients. Besides, the reach, efficacy, adoption, and implementation of using Hospital Fit as part of the physiotherapy treatment will be investigated from the perspective of both patients and healthcare professionals.
Status | Completed |
Enrollment | 180 |
Est. completion date | March 31, 2023 |
Est. primary completion date | March 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria patients: - Over 18 years old. - Receiving physiotherapy at the Medical Oncology Department or the Cardiology Department at the MUMC+ or Radboudumc. - Enough understanding of the Dutch language. - Owning a smartphone (operating system: at least iOS 13.0 or Android 8.0). - Able to use a smartphone app. - Able to walk independently 2 weeks before admission, as scored on the Functional Ambulation Categories (FAC >3). Exclusion Criteria patients: - A contraindication to walking (as reported by a medical specialist in the electronic medical record). - A contraindication to wearing an activity monitor, fixed by a hypoallergenic plaster at the upper leg (such as active bilateral upper leg infection, severe oedema or bilateral transfemoral amputation). - Admitted for cancers of the head and neck (i.e., cancer in the oral cavity, throat (pharynx), voice box (larynx), paranasal sinuses and nasal cavity, salivary glands). - Admitted with cardiac arrhythmia and hemodynamic instability requiring medication over 48 hours (i.e., beta blockers or noradrenaline) or invasive treatment (i.e., pacemaker or defibrillator implementation). - Mentally incapacitated subjects as reported by healthcare professionals in the medical record. When any doubt arises, the patient will be excluded. - Impaired cognition (delirium / dementia) as reported in the medical record by a healthcare professional. When any doubt arises, the patient will be excluded. - Unable to participate in the informed consent procedure or unable to provide written informed consent. - A life expectancy shorter than 3 months as mentioned by the medical specialist in the medical record. - Previous participation in this study. Inclusion Criteria healthcare professionals: - Employed as physiotherapist, nurse or physician (assistant) at the Medical Oncology Department or the Cardiology Department. - Working at the MUMC+ or Radboudumc for at least one month. Exclusion Criteria healthcare professionals: • No participation in care for patients at the Medical oncology Department or Cardiology Department during the intervention phase (e.g., absence or research employment). |
Country | Name | City | State |
---|---|---|---|
Netherlands | MaastrichtUMC | Maastricht | Limburg |
Netherlands | Radboudumc | Nijmegen | Gelderland |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center | Radboud University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Reach - Participation: Percentage of users (patients) of Hospital Fit that is reached in the intervention phase | The 'total number of users' (included patients allocated to the intervention group that used Hospital Fit) divided by the 'total number of included subjects' (all included patients allocated to the intervention group). A 'user' is defined included subject who has indicated that she/he used Hospital Fit at least once. | Period between inclusion and discharge with a maximum of nine days | |
Other | Reach - Representation: Patient characteristics of users and non-users in | Patient characteristics (i.e., age, gender, clinical diagnosis) of patients in the intervention group shown separate for users and non-users. A 'user' is defined included subject who has indicated that she/he used Hospital Fit at least once. A 'non-user' is an included subject who has indicated in the questionnaire that she/he did not use Hospital Fit. | Period between inclusion and discharge with a maximum of nine days | |
Other | Efficacy - Perceived efficacy | Data on perceived efficacy will be collected using individual, semi-structured, face-to-face interviews with 24 patients included in the intervention group and 4 focus group interviews with in total 6 healthcare professionals (physiotherapists, nurses, and physician(s) assistant(s)) per focus group. The following topics will be discussed: What is the impact of Hospital Fit use on physical activity of patients during their hospital stay according to patients? How do healthcare professionals determine if Hospital Fit use has been effective for patients? What were perceived positive and negative outcomes? How likely is it that Hospital Fit improved patients' physical activity? | Patient interviews at day of removal of accelerometer (=day of discharge or after max. 9 days of Hospital Fit use (whichever comes first)). Healthcareprofessional interviews: after the last patient has terminated the study (Jan.2023). | |
Other | Adoption - Use of app: Frequency of Hospital Fit use per day | Patients included in the intervention roup will score how many times per day she/he has used Hospital Fit on a daily questionnaire. | Period between inclusion and discharge, with a maximum of nine days | |
Other | Adoption - Use of different functionalities per day: Use of different functionalities of Hospital Fit | Patients included in the intervention group will score how many times per day the different functionalities of Hospital Fit were used on a daily questionnaire. | Period between inclusion and discharge, with a maximum of nine days | |
Other | Implementation - Barriers and facilitators to Hospital Fit use | Barriers and facilitators to Hospital Fit use according to patients allocated to the intervention group and healthcare professionals. This will be explored using individual, semi-structured, face-to-face interviews with 24 patients included in the intervention group and 4 focus group interviews with in total 6 healthcare professionals (physiotherapists, nurses, and physician(s) assistant(s)) per focus group. | Patient interviews at day of removal of accelerometer (=day of discharge or after max. 9 days of Hospital Fit use (whichever comes first)). Healthcareprofessional interviews: after the last patient has terminated the study (Jan.2023) | |
Other | Maintenance - Expected maintenance | Expected maintenance will be explored using individual, semi-structured, face-to-face interviews with 24 patients included in the intervention group and 4 focus group interviews with in total 6 healthcare professionals (physiotherapists, nurses, and physician(s) assistant(s)) per focus group. The following topics will be discussed: What might be the long-lasting effects of Hospital Fit on physical activity of patients? How will Hospital Fit be maintained at the hospital ward? | Patient interviews at day of removal of accelerometer (=day of discharge or after max. 9 days of Hospital Fit use (whichever comes first)). Healthcareprofessional interviews: after the last patient has terminated the study (Jan.2023) | |
Primary | Average time spent walking per day (minutes). | Total number of minutes walking divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of nine days. | Period between inclusion and discharge, with a maximum of nine days. | |
Secondary | Average time spent standing per day (minutes). | Total number of minutes standing divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of nine days. | Period between inclusion and discharge, with a maximum of nine days. | |
Secondary | Average time spent lying/sitting per day (minutes). | Total number of minutes lying/sitting divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of nine days. | Period between inclusion and discharge, with a maximum of nine days. | |
Secondary | Average number of transitions per day from a sedentary position (lying or sitting) to an active position (standing or walking). | Total number of transitions divided by the total number of valid measurement days in the period between inclusion and discharge, with a maximum of nine days. | Period between inclusion and discharge, with a maximum of nine days. | |
Secondary | Modified Iowa Level of Assistance scale (mILAS) scores per day. | The 5-item Modified Lowa Level of Assistance Scale (mILAS) assesses the ability of patients to perform 5 activities of daily living and rates the amount of assistance and type of walking aid needed. Each item has a 7-point rating scale (0-6 points), resulting in total scores ranging between 0-30 points. Higher scores indicate that a patient needs more assistance. | Period between inclusion and discharge, with a maximum of nine days. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|